| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDH10 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | RNF38 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | SSR1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | HLA-DMA | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | UQCC1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | ZNF570 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | ST8SIA2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | DACT3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | OLFML3 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | AARS2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
